. . . . . . . . . . . . "[The development of Her-2 DNA vaccine has progressed through three phases that can be categorized as phase A: the pursuit of Her-2 as a tumor-associated antigen, phase B: tilting the balance between tumor immunity and autoimmunity and phase C: the on-going clinical trials.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2016-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2016-05-13T12:46:42+02:00"^^ . . . . . . . . . . . "v4.0.0.0" . "v4.0.0" .